Human Growth Hormones'Somatropin'
http://www.humangrowthhormones.biz/somatropin.xml/
2008-11-20T19:47:59+01:00text/htmlPR Newswire - Critical Pharmaceuticals Raise GBP650K
http://www.humangrowthhormones.biz/human-growth-hormone/somatropin.xml/#pr-newswire----critical-pharmaceuticals-raise-gbp650k
November 10, 2008 -- Investors Endorse CriticalMix Drug Delivery Technology and own Pipeline Potential NOTTINGHAM, England, November 10 /PRNewswire/ -- Critical...text/htmlPR Newswire - FDA Approves Additional Indication for Norditropin® for Small for Gestational Age in Children
http://www.humangrowthhormones.biz/human-growth-hormone/somatropin.xml/#pr-newswire----fda-approves-additional-indication-for-norditropin®-for-small-for-gestational-age--in-children
November 6, 2008 -- Treatment Shown to Help Children Reach Normal Height PRINCETON, N.J., Nov. 4 /PRNewswire-FirstCall/ -- Children born with a condition that can...text/htmlBusiness Wire - An Essential Competitor Analysis Report on Human Growth Hormones : Biosimilar Pricing is Not Enough, Convenience Will Mandate
http://www.humangrowthhormones.biz/human-growth-hormone/somatropin.xml/#business-wire----an-essential-competitor-analysis-report-on-human-growth-hormones-:-biosimilar-pricing-is-not-enough,-convenience-will-mandate
October 8, 2008 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/6c5438/competitor_analysi) has announced the addition of the...text/htmlPR Newswire - Critical Pharmaceuticals Enter Sustained Release hGH Arena
http://www.humangrowthhormones.biz/human-growth-hormone/somatropin.xml/#pr-newswire----critical-pharmaceuticals-enter-sustained-release-hgh-arena
October 1, 2008 -- Preclinical Results of New Somatropin Formulation Demonstrate Advantages Over Existing Once-Daily Product NOTTINGHAM, England, October 1...text/htmlChain Drug Review - Omnitrope Pen 10 to hit market
http://www.humangrowthhormones.biz/human-growth-hormone/somatropin.xml/#chain-drug-review----omnitrope-pen-10-to-hit-market
September 29, 2008 -- PRINCETON, N.J. -- Sandoz has received Food and Drug Administration approval for its Omnitrope Pen 10 with liquid cartridge. Omnitrope, a somatropin,...text/htmlBusiness Wire - Tercica Initiates Phase II Clinical Trial with Next-Generation Growth Hormone Product for the Treatment of Short Stature
http://www.humangrowthhormones.biz/human-growth-hormone/somatropin.xml/#business-wire----tercica-initiates-phase-ii-clinical-trial-with-next-generation-growth-hormone-product-for-the-treatment-of-short-stature
January 22, 2008 -- BRISBANE, Calif. -- Tercica, Inc. (NASDAQ: TRCA) today announced that the Company has begun dosing the first patient in a Phase II clinical study...text/htmlPR Newswire Europe - FDA Approval of easypod(R): New Electronic Growth Hormone Injection Device.
http://www.humangrowthhormones.biz/human-growth-hormone/somatropin.xml/#pr-newswire-europe----fda-approval-of-easypod(r):-new-electronic-growth-hormone-injection-device.
November 8, 2007 -- GENEVA, Switzerland, November 8 /PRNewswire/ -- - Innovative Device Designed for Simple Everyday Use by Patients and Caregivers Merck...text/htmlBusiness Wire - Research and Markets: If the Biosimilar Industry is Going to Progress beyond the First Generation Biologics Then It Needs to Target More High Profile Therapies
http://www.humangrowthhormones.biz/human-growth-hormone/somatropin.xml/#business-wire----research-and-markets:-if-the-biosimilar-industry-is-going-to-progress-beyond-the-first-generation-biologics-then-it-needs-to-target-more-high-profile-therapies
October 26, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c72832) has announced the addition of new report from Espicom...text/htmlBusiness Wire - Osteologix CEO to Present at Eye for Pharma Early Commercialization, Lifecycle and Portfolio Management Congress 2007
http://www.humangrowthhormones.biz/human-growth-hormone/somatropin.xml/#business-wire----osteologix-ceo-to-present-at-eye-for-pharma-early-commercialization,-lifecycle-and-portfolio-management-congress-2007
October 24, 2007 -- October 25-26, Barcelo Sants Hotel, Barcelona SAN FRANCISCO -- Osteologix Inc. (OTCBB:OLGX) today announced that Philip J. Young, President and CEO...